REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

BOROSTYAN PHARMA Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: BOROSTYAN PHARMA Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

BOROSTYAN PHARMA Kft. is based in Hungary. The head office is in Tass. It operates in the Pharmacies and Drug Stores industry. It was first established on July 09, 2018. 4 (2024) employees currently work for BOROSTYAN PHARMA Kft.. From the latest financial highlights, BOROSTYAN PHARMA Kft. reported a net sales revenue increase of 13.9% in 2023. Its total assets grew by 119.17% over the same period. In 2023, BOROSTYAN PHARMA Kft.’s net profit margin increased by 0.45%.

Headquarters
Szechenyi ut 50.
Tass; Bacs-Kiskun; Postal Code: 6098

Contact Details: Purchase the BOROSTYAN PHARMA Kft. report to view the information.

Basic Information
Total Employees:
Purchase the BOROSTYAN PHARMA Kft. report to view the information.
Outstanding Shares:
Purchase the BOROSTYAN PHARMA Kft. report to view the information.
Registered Capital:
Purchase the BOROSTYAN PHARMA Kft. report to view the information.
Incorporation Date:
July 09, 2018
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after BOROSTYAN PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
13.9%▲
Total operating revenue
14.2%▲
Operating profit (EBIT)
22.6%▲
EBITDA
23.61%▲
Net Profit (Loss) for the Period
21.69%▲
Total assets
119.17%▲
Total equity
18.69%▲
Operating Profit Margin (ROS)
0.55%▲
Net Profit Margin
0.45%▲
Return on Equity (ROE)
2.18%▲
Quick Ratio
0.33%▲
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo